These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 29058301)

  • 1. Cancer-Testis Antigens as New Candidate Diagnostic Biomarkers for Transitional Cell Carcinoma of Bladder.
    Afsharpad M; Nowroozi MR; Mobasheri MB; Ayati M; Nekoohesh L; Saffari M; Zendehdel K; Modarressi MH
    Pathol Oncol Res; 2019 Jan; 25(1):191-199. PubMed ID: 29058301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ODF4, MAGEA3, and MAGEB4: Potential Biomarkers in Patients with Transitional Cell Carcinoma.
    Afsharpad M; Nowroozi MR; Ayati M; Saffari M; Nemati S; Mohebbi E; Nekoohesh L; Zendehdel K; Modarressi MH
    Iran Biomed J; 2018 May; 22(3):160-70. PubMed ID: 28865418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promoter hypermethylation of the 14-3-3 sigma, SYK and CAGE-1 genes is related to the various phenotypes of urinary bladder carcinomas and associated with progression of transitional cell carcinomas.
    Kunze E; Wendt M; Schlott T
    Int J Mol Med; 2006 Oct; 18(4):547-57. PubMed ID: 16964403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression profile of cancer-testis genes in transitional cell carcinoma of the bladder.
    Yin B; Liu G; Wang XS; Zhang H; Song YS; Wu B
    Urol Oncol; 2012; 30(6):886-92. PubMed ID: 21396841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of melanoma antigen gene in urinary transitional cell carcinomas].
    Geng L; Yu LZ; Du P; Ma M; Na YQ
    Zhonghua Wai Ke Za Zhi; 2005 May; 43(10):667-71. PubMed ID: 16008943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential molecular marker for detecting transitional cell carcinoma.
    Chiu AW; Huang YL; Huan SK; Wang YC; Ju JP; Chen MF; Chou CK
    Urology; 2002 Jul; 60(1):181-5. PubMed ID: 12100959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and clinical significance of Centrosomal protein 55 (CEP55) in human urinary bladder transitional cell carcinoma.
    Singh PK; Srivastava AK; Rath SK; Dalela D; Goel MM; Bhatt ML
    Immunobiology; 2015 Jan; 220(1):103-8. PubMed ID: 25178936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clusterin as a diagnostic and prognostic marker for transitional cell carcinoma of the bladder.
    Hazzaa SM; Elashry OM; Afifi IK
    Pathol Oncol Res; 2010 Mar; 16(1):101-9. PubMed ID: 19757199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of transitional cell-specific genes, uroplakin Ia and II, in bladder cancer: detection of circulating cancer cells in the peripheral blood of metastatic patients.
    Yuasa T; Yoshiki T; Isono T; Tanaka T; Hayashida H; Okada Y
    Int J Urol; 1999 Jun; 6(6):286-92. PubMed ID: 10404304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective evaluation of the diagnostic and potential prognostic utility of urinary human telomerase reverse transcriptase mRNA in patients with bladder cancer.
    Bowles L; Bialkowska-Hobrzanska H; Bukala B; Nott L; Razvi H
    Can J Urol; 2004 Dec; 11(6):2438-44. PubMed ID: 15636669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S100A12 and RAGE expression in human bladder transitional cell carcinoma: a role for the ligand/RAGE axis in tumor progression?
    Khorramdelazad H; Bagheri V; Hassanshahi G; Karami H; Moogooei M; Zeinali M; Abedinzadeh M
    Asian Pac J Cancer Prev; 2015; 16(7):2725-9. PubMed ID: 25854354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical relevance of maspin expression in bladder cancer.
    Beecken WD; Engl T; Engels K; Blumenberg C; Oppermann E; Camphausen K; Shing Y; Reinecke G; Jonas D; Blaheta R
    World J Urol; 2006 Aug; 24(3):338-44. PubMed ID: 16832651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of CDH13 promoter methylation in serum samples from patients with bladder transitional cell carcinoma.
    Lin YL; Sun G; Liu XQ; Li WP; Ma JG
    J Int Med Res; 2011; 39(1):179-86. PubMed ID: 21672320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early diagnosis and monitoring of superficial transitional cell carcinoma by microsatellite analysis on urine sediment.
    Bartoletti R; Dal Canto M; Cai T; Piazzini M; Travaglini F; Gavazzi A; Rizzo M
    Oncol Rep; 2005 Mar; 13(3):531-7. PubMed ID: 15706429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of apoptosis inhibitor gene Livin in bladder transitional cell carcinoma and clinical implication thereof].
    Song T; Hong BF; Gao JP; Cai W; Wang CY
    Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(12):806-7. PubMed ID: 17565859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate stem cell antigen is overexpressed in human transitional cell carcinoma.
    Amara N; Palapattu GS; Schrage M; Gu Z; Thomas GV; Dorey F; Said J; Reiter RE
    Cancer Res; 2001 Jun; 61(12):4660-5. PubMed ID: 11406532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of CD147, BIGH3 and Stathmin and their potential role as diagnostic marker in patients with urothelial carcinoma of the bladder.
    Bhagirath D; Abrol N; Khan R; Sharma M; Seth A; Sharma A
    Clin Chim Acta; 2012 Oct; 413(19-20):1641-6. PubMed ID: 22626996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative analysis of survivin mRNA expression in urine and tumor tissue of bladder cancer patients and its potential relevance for disease detection and prognosis.
    Weikert S; Christoph F; Schrader M; Krause H; Miller K; Müller M
    Int J Cancer; 2005 Aug; 116(1):100-4. PubMed ID: 15761870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency of NY-ESO-1 and LAGE-1 expression in bladder cancer and evidence of a new NY-ESO-1 T-cell epitope in a patient with bladder cancer.
    Sharma P; Gnjatic S; Jungbluth AA; Williamson B; Herr H; Stockert E; Dalbagni G; Donat SM; Reuter VE; Santiago D; Chen YT; Bajorin DF; Old LJ
    Cancer Immun; 2003 Dec; 3():19. PubMed ID: 14680360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chorionic gonadotropin beta-subunit and core fragment in bladder cancer: mRNA and protein expression in urine, serum and tissue.
    Hotakainen K; Haglund C; Paju A; Nordling S; Alfthan H; Rintala E; Stenman UH
    Eur Urol; 2002 Jun; 41(6):677-85. PubMed ID: 12074787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.